Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohortAndrea Serafin, Andrea Visentin, Alessandro Cellini et al.|Blood Advances|2025Cited by 3
Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment?Francesco Autore, Luca Laurenti, Alessandra Tedeschi et al.|Blood|2023Cited by 0
Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre StudyFrancesco Autore, Luca Laurenti, Emanuele Cencini et al.|Blood|2024Cited by 0